Cleared Traditional

K834209 - STRATUS THYROID UPTAKE FLUOROMETRIC

K834209 is the FDA 510(k) clearance for STRATUS THYROID UPTAKE FLUOROMETRIC by American Dade. It is a Class 2 Chemistry device (product code KHQ) cleared through the Traditional 510(k) pathway after a 95-day FDA review.

K834209 · American Dade · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1984
Decision
95d
Days
Class 2
Risk

K834209 is an FDA 510(k) clearance for the STRATUS THYROID UPTAKE FLUOROMETRIC. Classified as Radioassay, Triiodothyronine Uptake (product code KHQ), Class II - Special Controls.

Submitted by American Dade (Mchenry, US). The FDA issued a Cleared decision on March 9, 1984 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1715 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all American Dade devices

Submission Details

510(k) Number K834209 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1983
Decision Date March 09, 1984
Days to Decision 95 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 88d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KHQ Radioassay, Triiodothyronine Uptake
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - KHQ Radioassay, Triiodothyronine Uptake

All 53
Devices cleared under the same product code (KHQ) and FDA review panel - the closest regulatory comparables to K834209.
MMS T3 UPTAKE
K861262 · Micromedic Systems · May 1986
STRAT THYROID UPTAKE FLUROMET ENZYME IMMUNOASSAY
K860422 · American Dade · Apr 1986
TERUMO SENSIBEAD EIA THYROID UPTAKE KIT
K842694 · Terumo Medical Corp. · Sep 1984
ACA THYROXINE UPTAKE ANALYTICAL TEST
K833703 · E.I. Dupont DE Nemours & Co., Inc. · Jan 1984
MAGIC TM 125I T3 UPTAKE RADIOASSAY
K831613 · Corning Medical & Scientific · Aug 1983
TDX T-UPTAKE
K830912 · Abbott Laboratories · Apr 1983